Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated)
090701
Phase 3 mab completed
Quick answer
Factor VIII Inhibitor Bypassing Activity (nanofiltered, vapor heat-treated) for Hemophilia A or B With Inhibitors is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hemophilia A or B With Inhibitors
- Phase
- Phase 3
- Modality
- mab
- Status
- completed